Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Elements modulating the prion species barrier and its passage consequences.

Torres JM, Espinosa JC, Aguilar-Calvo P, Herva ME, Relaño-Ginés A, Villa-Diaz A, Morales M, Parra B, Alamillo E, Brun A, Castilla J, Molina S, Hawkins SA, Andreoletti O.

PLoS One. 2014 Mar 7;9(3):e89722. doi: 10.1371/journal.pone.0089722. eCollection 2014.

2.

Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.

Espinosa JC, Andréoletti O, Castilla J, Herva ME, Morales M, Alamillo E, San-Segundo FD, Lacroux C, Lugan S, Salguero FJ, Langeveld J, Torres JM.

J Virol. 2007 Jan;81(2):835-43. Epub 2006 Nov 1.

3.

Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features.

Vidal E, Fernández-Borges N, Pintado B, Ordóñez M, Márquez M, Fondevila D, Torres JM, Pumarola M, Castilla J.

J Neurosci. 2013 May 1;33(18):7778-86. doi: 10.1523/JNEUROSCI.0244-13.2013.

4.

L-type bovine spongiform encephalopathy in genetically susceptible and resistant sheep: changes in prion strain or phenotypic plasticity of the disease-associated prion protein?

Nicot S, Bencsik A, Migliore S, Canal D, Leboidre M, Agrimi U, Nonno R, Baron T.

J Infect Dis. 2014 Mar;209(6):950-9. doi: 10.1093/infdis/jit596. Epub 2013 Nov 11.

5.

Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.

Manuelidis L, Liu Y, Mullins B.

J Cell Biochem. 2009 Feb 1;106(2):220-31. doi: 10.1002/jcb.21988.

6.

Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy infection following passage in sheep.

Plinston C, Hart P, Chong A, Hunter N, Foster J, Piccardo P, Manson JC, Barron RM.

J Virol. 2011 Feb;85(3):1174-81. doi: 10.1128/JVI.01578-10. Epub 2010 Nov 17.

7.

Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein.

Castilla J, Gutiérrez-Adán A, Brun A, Doyle D, Pintado B, Ramírez MA, Salguero FJ, Parra B, Segundo FD, Sánchez-Vizcaíno JM, Rogers M, Torres JM.

J Neurosci. 2004 May 26;24(21):5063-9.

8.

Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies.

Priem J, Langeveld JP, van Keulen LJ, van Zijderveld FG, Andreoletti O, Bossers A.

J Virol. 2014 Mar;88(5):2903-12. doi: 10.1128/JVI.02446-13. Epub 2013 Dec 26.

9.

Overexpression of chimaeric murine/ovine PrP (A136H154Q171) in transgenic mice facilitates transmission and differentiation of ruminant prions.

Griffiths PC, Plater JM, Chave A, Jayasena D, Tout AC, Rice PB, Vickery CM, Spiropoulos J, Stack MJ, Windl O.

J Gen Virol. 2013 Nov;94(Pt 11):2577-86. doi: 10.1099/vir.0.051581-0. Epub 2013 Jun 12.

PMID:
23761404
10.

Transmission barriers for bovine, ovine, and human prions in transgenic mice.

Scott MR, Peretz D, Nguyen HO, Dearmond SJ, Prusiner SB.

J Virol. 2005 May;79(9):5259-71.

11.

Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie.

Espinosa JC, Herva ME, Andréoletti O, Padilla D, Lacroux C, Cassard H, Lantier I, Castilla J, Torres JM.

Emerg Infect Dis. 2009 Aug;15(8):1214-21. doi: 10.3201/eid1508.081218.

12.

Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice.

Padilla D, Béringue V, Espinosa JC, Andreoletti O, Jaumain E, Reine F, Herzog L, Gutierrez-Adan A, Pintado B, Laude H, Torres JM.

PLoS Pathog. 2011 Mar;7(3):e1001319. doi: 10.1371/journal.ppat.1001319. Epub 2011 Mar 17.

13.

Transgenic models of prion disease.

Scott MR, Supattapone S, Nguyen HO, DeArmond SJ, Prusiner SB.

Arch Virol Suppl. 2000;(16):113-24. Review.

PMID:
11214913
14.

Bovine PrP expression levels in transgenic mice influence transmission characteristics of atypical bovine spongiform encephalopathy.

Wilson R, Hart P, Piccardo P, Hunter N, Casalone C, Baron T, Barron RM.

J Gen Virol. 2012 May;93(Pt 5):1132-40. doi: 10.1099/vir.0.040030-0. Epub 2012 Feb 1.

15.

Early detection of PrPres in BSE-infected bovine PrP transgenic mice.

Castilla J, Gutiérrez Adán A, Brun A, Pintado B, Ramírez MA, Parra B, Doyle D, Rogers M, Salguero FJ, Sánchez C, Sánchez-Vizcaíno JM, Torres JM.

Arch Virol. 2003 Apr;148(4):677-91.

PMID:
12664293
16.

Unaltered susceptibility to BSE in transgenic mice expressing human prion protein.

Collinge J, Palmer MS, Sidle KC, Hill AF, Gowland I, Meads J, Asante E, Bradley R, Doey LJ, Lantos PL.

Nature. 1995 Dec 21-28;378(6559):779-83. Erratum in: Nature 1997 Oct 2;389(6650):526.

PMID:
8524411
17.

Atypical scrapie prions from sheep and lack of disease in transgenic mice overexpressing human prion protein.

Wadsworth JD, Joiner S, Linehan JM, Balkema-Buschmann A, Spiropoulos J, Simmons MM, Griffiths PC, Groschup MH, Hope J, Brandner S, Asante EA, Collinge J.

Emerg Infect Dis. 2013 Nov;19(11):1731-9. doi: 10.3201/eid1911.121341.

18.

Transmissibility of H-Type Bovine Spongiform Encephalopathy to Hamster PrP Transgenic Mice.

Okada H, Masujin K, Miyazawa K, Yokoyama T.

PLoS One. 2015 Oct 14;10(10):e0138977. doi: 10.1371/journal.pone.0138977. eCollection 2015.

19.

Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice.

Scott MR, Safar J, Telling G, Nguyen O, Groth D, Torchia M, Koehler R, Tremblay P, Walther D, Cohen FE, DeArmond SJ, Prusiner SB.

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14279-84.

20.

BSE: can we predict the future?

Plum J.

Bull Mem Acad R Med Belg. 1997;152(6):264-73.

PMID:
9581370
Items per page

Supplemental Content

Write to the Help Desk